Search Results - "Frias, Edwin C."

Serological response to vaccination in post-acute sequelae of COVID by Joung, Sandy, Weber, Brittany, Wu, Min, Liu, Yunxian, Tang, Amber B, Driver, Matthew, Sternbach, Sarah, Wynter, Timothy, Hoang, Amy, Barajas, Denisse, Kao, Yu Hung, Khuu, Briana, Bravo, Michelle, Masoom, Hibah, Tran, Teresa, Sun, Nancy, Botting, Patrick G, Claggett, Brian L, Prostko, John C, Frias, Edwin C, Stewart, James L, Robertson, Jackie, Kwan, Alan C, Torossian, Mariam, Pedraza, Isabel, Sterling, Carina, Goldzweig, Caroline, Oft, Jillian, Zabner, Rachel, Fert-Bober, Justyna, Ebinger, Joseph E, Sobhani, Kimia, Cheng, Susan, Le, Catherine N

“…Individuals with post-acute sequelae of COVID (PASC) may have a persistence in immune activation that differentiates them from individuals who have recovered…”
Get full text

Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis by Ebinger, Joseph E, Joung, Sandy, Liu, Yunxian, Wu, Min, Weber, Brittany, Claggett, Brian, Botting, Patrick G, Sun, Nancy, Driver, Matthew, Kao, Yu Hung, Khuu, Briana, Wynter, Timothy, Nguyen, Trevor-Trung, Alotaibi, Mona, Prostko, John C, Frias, Edwin C, Stewart, James L, Goodridge, Helen S, Chen, Peter, Jordan, Stanley C, Jain, Mohit, Sharma, Sonia, Fert-Bober, Justyna, Van Eyk, Jennifer E, Minissian, Margo B, Arditi, Moshe, Melmed, Gil Y, Braun, Jonathan G, McGovern, Dermot P B, Cheng, Susan, Sobhani, Kimia

“…ObjectivesWe sought to understand the demographic and clinical factors associated with variations in longitudinal antibody response following completion of…”
Get full text

Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease by Xu, Alexander M, Li, Dalin, Ebinger, Joseph E, Mengesha, Emebet, Elyanow, Rebecca, Gittelman, Rachel M, Chapman, Heidi, Joung, Sandy, Botwin, Gregory J, Pozdnyakova, Valeriya, Debbas, Philip, Mujukian, Angela, Prostko, John C, Frias, Edwin C, Stewart, James L, Horizon, Arash A, Merin, Noah, Sobhani, Kimia, Figueiredo, Jane C, Cheng, Susan, Kaplan, Ian M, McGovern, Dermot P B, Merchant, Akil, Melmed, Gil Y, Braun, Jonathan

“…T-cells specifically bind antigens to induce adaptive immune responses using highly specific molecular recognition, and a diverse T-cell repertoire with…”
Get full text

Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2 by Ebinger, Joseph E., Fert-Bober, Justyna, Printsev, Ignat, Wu, Min, Sun, Nancy, Prostko, John C., Frias, Edwin C., Stewart, James L., Van Eyk, Jennifer E., Braun, Jonathan G., Cheng, Susan, Sobhani, Kimia

“…In a cohort of BNT162b2 (Pfizer–BioNTech) mRNA vaccine recipients ( n  = 1,090), we observed that spike-specific IgG antibody levels and ACE2 antibody binding…”
Get full text

Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following Prior Infection or Vaccination by Ebinger, Joseph E, Sun, Nancy, Joung, Sandy Y, Sanchez, John Michael S, Wang, Minhao, Liu, Yunxian, Prostko, John C, Frias, Edwin C, Stewart, James L, Heath, Mallory, Claggett, Brian L, Cheng, Susan, Sobhani, Kimia

“…Abstract Background The extent to which infection versus vaccination has conferred similarly durable severe acute respiratory syndrome coronavirus 2…”
Get full text

Longitudinal SARS-CoV-2 mRNA Vaccine-Induced Humoral Immune Responses in Patients with Cancer by Figueiredo, Jane C, Merin, Noah M, Hamid, Omid, Choi, So Yung, Lemos, Tucker, Cozen, Wendy, Nguyen, Nathalie, Finster, Laurel J, Foley, Joslyn, Darrah, Justin, Gong, Jun, Paquette, Ronald, Mita, Alain C, Vescio, Robert, Mehmi, Inderjit, Basho, Reva, Tourtellotte, Warren G, Huynh, Carissa A, Melmed, Gil Y, Braun, Jonathan, McGovern, Dermot P B, Mengesha, Emebet, Botwin, Greg, Prostko, John C, Frias, Edwin C, Stewart, James L, Joung, Sandy, Van Eyk, Jennifer, Ebinger, Joseph E, Cheng, Susan, Sobhani, Kimia, Reckamp, Karen L, Merchant, Akil

“…Longitudinal studies of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine-induced immune responses in patients with cancer are needed to…”
Get full text

Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel Disease by Pozdnyakova, VALERIYA, Botwin, GREGORY J., Sobhani, KIMIA, Prostko, JOHN, Braun, JONATHAN, Mcgovern, DERMOT P.B., Melmed, GIL Y., Appel, Keren, Banty, Andrea, Feldman, Edward, Ha, Christina, Kumar, Rashmi, Lee, Susie, Rabizadeh, Shervin, Stein, Theodore, Syal, Gaurav, Targan, Stephan, Vasiliauskas, Eric, Ziring, David, Debbas, Philip, Hampton, Melissa, Mengesha, Emebet, Stewart, James L., Frias, Edwin C., Cheng, Susan, Ebinger, Joseph, Figueiredo, Jane C., Boland, Brigid, Charabaty, Aline, Chiorean, Michael, Cohen, Erica, Flynn, Ann, Valentine, John, Fudman, David, Horizon, Arash, Hou, Jason, Hwang, Caroline, Lazarev, Mark, Lum, Donald, Fausel, Rebecca, Reddy, Swapna, Mattar, Mark, Metwally, Mark, Ostrov, Arthur, Parekh, Nimisha, Raffals, Laura, Sheibani, Sarah, Siegel, Corey, Wolf, Douglas, Younes, Ziad

Get full text

The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy by Li, Dalin, Xu, Alexander, Mengesha, Emebet, Elyanow, Rebecca, Gittelman, Rachel M, Chapman, Heidi, Prostko, John C, Frias, Edwin C, Stewart, James L, Pozdnyakova, Valeriya, Debbas, Philip, Mujukian, Angela, Horizon, Arash A, Merin, Noah, Joung, Sandy, Botwin, Gregory J, Sobhani, Kimia, Figueiredo, Jane C, Cheng, Susan, Kaplan, Ian M, McGovern, Dermot P B, Merchant, Akil, Melmed, Gil Y, Braun, Jonathan

“…Lay Summary T-cell and antibody responses to severe acute respiratory syndrome coronavirus 2 vaccination in inflammatory bowel disease patients are poorly…”
Get full text

Long‐term durability of antibody responses after SARS‐CoV‐2 vaccination and influencing factors by Ebinger, Joseph E., Joung, Sandy Y., Wang, Minhao, Liu, Yunxian, Prostko, John C., Frias, Edwin C., Stewart, James L., Braun, Jonathan, McGovern, Dermot P. B., Melmed, Gil Y., Jordan, Stanley C., Claggett, Brian L., Sobhani, Kimia, Cheng, Susan

Get full text

Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity by Joung, Sandy Y., Ebinger, Joseph E., Sun, Nancy, Liu, Yunxian, Wu, Min, Tang, Amber B., Prostko, John C., Frias, Edwin C., Stewart, James L., Sobhani, Kimia, Cheng, Susan

“…Importance Some individuals who were infected by the SARS-CoV-2 Omicron variant may have been completely unaware of their infectious status while the virus was…”
Get full text

Postvaccination Symptoms After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease: A Prospective, Comparative Study by Mujukian, Angela, Kumar, Rashmi, Li, Dalin, Debbas, Philip, Botwin, Gregory J, Cheng, Susan, Ebinger, Joseph, Braun, Jonathan, McGovern, Dermot, Melmed, Gil Y

“…Vaccine hesitancy is prevalent among people with IBD, in part due to insufficient evidence regarding comparative safety of vaccines in this population. We…”
Get full text

Specificity and Confirmation of SARS-CoV-2 Serological Test Methods in Emergency Department Populations across the United States by Daghfal, David J, Schneider, Randal J, Mohr, Phaedre, Frias, Edwin C, Prostko, John C, Sokoll, Lori J

“…Serological testing for SARS-CoV-2 is integral for understanding prevalence of disease, tracking of infections, confirming humoral response to vaccines, and…”
Get full text

Engineering of the hepatitis C virus helicase for enhanced seroreactivity by Marohnic, Christopher C., Birkenmeyer, Larry G., Bogdan, M. Felicia, Frias, Edwin C., Otis, Kathy S., Palafox, Mary Ann P., McSherry, Troy D., Gregory, Svetoslava D., Zhao, Cheng, Gutierrez, Robin A., Prostko, John C., Muerhoff, A. Scott

“…•Cysteine mutations within HCV 33c antigen can improve antibody detection.•Most 33c epitopes are within NS3 helicase domain 1 (aa 1192–1353).•HCV helicase…”
Get full text

Longitudinal SARS-CoV-2 mRNA vaccine-induced humoral immune responses in cancer patients by Figueiredo, Jane C., Merin, Noah M., Hamid, Omid, Choi, So Yung, Lemos, Tucker, Cozen, Wendy, Nguyen, Nathalie, Finster, Laurel J., Foley, Joslyn, Darrah, Justin, Gong, Jun, Paquette, Ronald, Mita, Alain C., Vescio, Robert, Mehmi, Inderjit, Basho, Reva, Tourtellotte, Warren G., Huynh, Carissa A., Melmed, Gil Y., Braun, Jonathan, McGovern, Dermot P.B., Mengesha, Emebet, Botwin, Greg, Prostko, John C., Frias, Edwin C, Stewart, James L., Joung, Sandy, Van Eyk, Jennifer, Ebinger, Joseph E., Cheng, Susan, Sobhani, Kimia, Reckamp, Karen L., Merchant, Akil

“…Longitudinal studies of SARS-CoV-2 vaccine-induced immune responses in cancer patients are needed to optimize clinical care. In a prospective cohort study of…”
Get full text

Specificity and Confirmation of SARS-CoV-2 Serological Test Methods in Emergency Department Populations Across the United States in 2019 and Early 2020 by Daghfal, David J, Schneider, Randal J, Mohr, Phaedre, Frias, Edwin C, Prostko, John C, Sokoll, Lori J

“…Serological testing for SARS-CoV-2 is integral for understanding prevalence of disease, tracking of infections, confirming humoral response to vaccines, and…”
Get full text